デニス・ドラッシュ症候群と再発したウィルムズ腫瘍における腎臓保存と腫瘍学的アウトカムを調和させる. ケースベースの議論
Michael Dubic1, Kayla Schilling Graham1, Michael Smigelski2
1Atrium Health Carolinas Medical Center, Department of Urology, 1225 Harding Place Charlotte Unit 3100, NC 28204.
Urology
|September 3, 2025
まとめ
デニス・ドラッシュ症候群 (DDS) は,まれな遺伝的疾患で,典型的には子供の頃に発現します. この症例は 腎臓病と新しい腫瘍を患っている 成人のDDS患者を強調し 複雑な管理上の課題を強調しています
科学分野:
- 遺伝学 と 分子 生物学
- 小児腎臓科
- 腫瘍学
背景:
- デニス・ドラッシュ症候群 (DDS) は,WT1遺伝子変異によって引き起こされる珍しい遺伝疾患です.
- 古典的なDDSの表現には,早期発症の末期腎疾患 (ESRD),性発達障害 (DSD),および高いウィルムズ腫瘍 (WT) のリスクが含まれます.
- 患者特有の臨床的特徴に基づいて管理が高度に個別化されています.
研究 の 目的:
- 成人DDSの珍しい症例を報告する
- DDSの文脈でウィルムズ腫瘍の管理について議論します.
- 特に WT に関する DDS 患者の管理の複雑さを検討する.
主な方法:
- デニス・ドラッシュ症候群の 成人患者の症例報告
- 機能的な腎臓組織と新しい腎臓質量を含む臨床表現の見直し
- 過去のウィルムズ腫瘍治療と現在の管理戦略の検討
主要な成果:
- デニス・ドラッシュ症候群の 稀な成人の症例を紹介する
- 患者の本来の腎臓組織は機能し 新しい腎臓質量がありました
- 子どもの頃のウィルムズ腫瘍の治療歴を記録した.
結論:
- デニス・ドラッシュ症候群の成人の発現は珍しいが,可能である.
- DDSの管理には,特に同時進行中のウィルムズ腫瘍では,多学科的なアプローチが必要です.
- このケースは DDS患者の長期的な複雑性と監視の必要性を強調しています
関連する概念動画
01:16Kidney Transplant III: Nursing Management
80
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
80
01:28Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
01:06Renal Drug Clearance: Overview
325
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
325
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:11Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152
01:18Chronic Kidney Disease IV: Nursing Management
54
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
54